115 related articles for article (PubMed ID: 6439411)
21. ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.
Dirisamer A; Stadler A; Bucek RA; Widhalm K
Acta Paediatr; 2006 Jul; 95(7):810-3. PubMed ID: 16801176
[TBL] [Abstract][Full Text] [Related]
22. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
[TBL] [Abstract][Full Text] [Related]
23. [Plasma apolipoproteins: their role in cardiovascular diseases and usefulness of their blood concentration determination. Committee of the Study of Apolipoproteins, Italian Heart Foundation].
Cardiologia; 1997 Feb; 42 Suppl 1():1-39. PubMed ID: 9147845
[No Abstract] [Full Text] [Related]
24. [A simple procedure for the simultaneous determination of apolipoproteins AI and B using rocket immunoelectrophoresis].
Oswald B; Winkler L; Schlag B; Dargel R
Z Med Lab Diagn; 1984; 25(8):411-6. PubMed ID: 6441367
[No Abstract] [Full Text] [Related]
25. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
Meisinger C; Loewel H; Mraz W; Koenig W
Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061
[TBL] [Abstract][Full Text] [Related]
26. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).
Holme I; Aastveit AH; Jungner I; Walldius G
J Intern Med; 2008 Jul; 264(1):30-8. PubMed ID: 18298486
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).
Dunder K; Lind L; Zethelius B; Berglund L; Lithell H
Am Heart J; 2004 Oct; 148(4):596-601. PubMed ID: 15459588
[TBL] [Abstract][Full Text] [Related]
28. Consider lipoprotein(a), not just apolipoprotein B, when determining low-density lipoprotein for lipoprotein profiles.
Doetsch K
Clin Chem; 1990 Oct; 36(10):1857-8. PubMed ID: 2208679
[No Abstract] [Full Text] [Related]
29. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men.
Lind L; Vessby B; Sundström J
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):406-10. PubMed ID: 16306426
[TBL] [Abstract][Full Text] [Related]
30. [The relationship of apolipoprotein H G1025C (Try316Ser) polymorphism with stroke and its effect on plasma lipid levels in Changsha Hans].
Xia J; Yang Q; Yang Q; Xu H; Zhang L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):114-8. PubMed ID: 12673579
[TBL] [Abstract][Full Text] [Related]
31. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy.
Walldius G; Jungner I
Eur Heart J; 2005 Feb; 26(3):210-2. PubMed ID: 15618031
[No Abstract] [Full Text] [Related]
32. Fasting specimens not required for routine measurement of plasma apolipoproteins A-I and B.
Hester J; Shephard MD; Walmsley RN; White GH
Ann Clin Biochem; 1989 Jul; 26 ( Pt 4)():374-5. PubMed ID: 2504103
[No Abstract] [Full Text] [Related]
33. Standardization of apolipoprotein measurements.
Cooper GR; Smith SJ; Henderson LO; Hannon WH
Prog Clin Biol Res; 1988; 255():155-74. PubMed ID: 3124130
[No Abstract] [Full Text] [Related]
34. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
Jungner I; Sniderman AD; Furberg C; Aastveit AH; Holme I; Walldius G
Am J Cardiol; 2006 Apr; 97(7):943-6. PubMed ID: 16563891
[TBL] [Abstract][Full Text] [Related]
35. Plasma lipids, lipoproteins and apoproteins B and A-I before and after a 24 h endurance race in cross-country skiers.
Zuliani U; Bonetti A; Cerioli G; Catapano A; Zeppilli P
J Sports Med Phys Fitness; 1986 Mar; 26(1):8-10. PubMed ID: 3086623
[No Abstract] [Full Text] [Related]
36. Measurement of apolipoproteins B and A by radial immunodiffusion: methodological assessment and clinical applications.
Cano MD; Gonzalvo C; Scheen AJ; Castillo MJ
Ann Biol Clin (Paris); 1994; 52(9):657-61. PubMed ID: 7872515
[TBL] [Abstract][Full Text] [Related]
37. Mapping of lipoprotein particles with monoclonal antibodies in diabetes and atherosclerosis.
Fievet C; Parra H; Luyeye I; Demarquilly C; Fievet P; Fruchart JC; Bertrand M; Lablanche JM; Drouin P; Gross P
Monogr Atheroscler; 1985; 13():134-41. PubMed ID: 3937049
[No Abstract] [Full Text] [Related]
38. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
39. RIECA: an innovative immuno enzymatic competition assay for apolipoproteins AI and B determination.
Galliani S; Tosi C; Guintini I; Mariani C; de Lalla C; Da Ros B; Rossi P; Baralle FE; Sidoli A
Ann Biol Clin (Paris); 1990; 48(6):398-402. PubMed ID: 2121074
[TBL] [Abstract][Full Text] [Related]
40. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
Jenner JL; Seman LJ; Millar JS; Lamon-Fava S; Welty FK; Dolnikowski GG; Marcovina SM; Lichtenstein AH; Barrett PH; deLuca C; Schaefer EJ
Metabolism; 2005 Mar; 54(3):361-9. PubMed ID: 15736114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
